Modulated Zirconia nanotube for controlled drug release

16 August 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

The integration of drug delivery coating in orthopedic applications is attracting interest due to its potential to improve the success rate of implant systems. Several published reports have focused on the aspect of controlled drug release to aid in the optimization of drug delivery. Herein, we report on a novel and simple approach to extending drug release time and limiting the undesirable burst release from Zirconia nanotube (ZrNT) via structural modification. The structural modification involves fabricating a double-layered structure with a modulated diameter and is achieved via voltage adjustment during electrochemical anodization. The drug loading and release studies from the structurally modified ZrNTs, characterized via SEM and Tof-SIMS were monitored using UV-Visible spectrometry and compared with their homogenously thick equivalents. We report a significant reduction in the initial burst release phenomenon and an improvement in overall release time. The simple structural modification of ZrNT successfully enhances drug release performance, allows for flexibility in designing drug delivery coatings for specific implant challenges, and offers new insights into alternate biomaterials based on metal-oxide nanostructures.

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.